PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550678
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550678
Pet Diabetes Care Devices Market, By Animal Type, By Solutions (Treatment, and Glucose Monitoring Devices), By End User, By Geography
The global pet diabetes care devices market is estimated to be valued at USD 2.42 Billion in 2024 and is expected to reach USD 3.91 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 2.42 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.10% | 2031 Value Projection: | US$ 3.91 Bn |
The global pet diabetes care devices market has been witnessing significant growth in the recent times. Rising pet obesity levels and increasing pet humanization have resulted in greater awareness about pet health, preventive care, and treatment of pet diseases. Pet owners are making active efforts towards monitoring blood glucose levels and managing diabetes in pets through insulin administration and therapeutic diet. Various technologies have been developed for diabetes management in pets which enables the non-invasive monitoring and administration of insulin doses. Advancements in continuous glucose monitoring (CGM) systems, insulin pumps, and lancing devices have simplified diabetes care for pets. Growing pet insurance coverage and rising pet care expenditure also supports the demand for specialized pet diabetes care devices. However, high cost of devices and therapy remains a key challenge for market growth.
(Market Dynamics):
Key factors, such as rising pet obesity, growing pet ownership in developing nations, increasing awareness about pet health and disease management, new product launches, and technological advancements, are fueling the growth of global pet diabetes care devices market. However, high cost associated with glucose monitoring devices, therapy and veterinary care is a major factor hampering the widespread adoption of these technologies. Market players are focusing on developing affordable solutions through innovations to expand their customer base in developing regions. Rising venture capital funding in pet care startups indicate strong opportunities for development of novel solutions as well as penetration in untapped markets.
(Key Features of the Study):
This report provides in-depth analysis of the global pet diabetes care devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pet diabetes care devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., i-SENS, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pet diabetes care devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet diabetes care devices market.
Detailed Segmentation-
- By Animal Type
- Dogs
- Cats
- By Solutions
- Treatment
- Insulin Therapy
- Insulin Delivery Devices
- Other Treatments
- Glucose Monitoring Devices
- By End User
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Key Players Insights
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
- i-SENS, Inc.
Table of Contents
1. Research objectives and assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Pet Diabetes Care Devices Market, By Animal Type
- Global Pet Diabetes Care Devices Market, By Solutions
- Global Pet Diabetes Care Devices Market, By End User
- Global Pet Diabetes Care Devices Market, By Region
3. Market dynamics, regulations, and trends analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Pet Diabetes Care Devices Market, By Animal Type, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Pet Diabetes Care Devices Market, By Solutions, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Insulin Therapy
- Insulin Delivery Devices
- Other Treatments
- Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Pet Diabetes Care Devices Market, By End User, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Pet Diabetes Care Devices Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- U.S.
- Canada
- Latin America
- Introduction
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- South Africa
- North Africa
- Central Africa
8. COMPETITIVE LANDSCAPE
- Abbot Laboratories, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- i-SENS, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
